Unsaved Changes
You have unsaved changes, are you sure you want to leave this page?
Salt Lake City, Salt Lake County, Utah
Asking Price
$15,000,000
Revenue
$2,000,000
Down
Call/Email
Cash Flow
$700,000
Name: Rick Carlson
Phone: Show phone number
Name
Rick Carlson
Phone
Show phone number
Posting ID:
288836
Attributes:
Broker Cooperation
Financial Assistance
Owner/Seller Financing
Training And Support
Recommended Businesses
Charleston, South Carolina
Cask Strength Bourbon Brand - High Proof
Call/Email
CF : $ 300,000
Our client sources an excellent quality bourbon that has a higher yield than a traditional 6-8-year aged bourbon. Due to the higher yield because of less evaporation, they are able to keep the MSRP very competitive and are growing rapidly. They partner with a smaller craft distillery as their co-packer in order to keep production costs down. The founder is a rising, Tennessee-based singer/songwriter with thousands of followers. He uses, and will continue to use, his social media and concerts to publicize the bourbon and allows fans to become partial minority owners of the brand, thus far garnering approximately $200,000 as of the beginning of December 2022. Since the launch of the bourbon brand in 2018 it has earned some of the largest and most prestigious awards which can be awarded in the spirit industry. 1) Named Top 6 in the World in Forbes 2) Featured in Billboard, Rolling Stone, Uproxx, American Songwriter 3) Platinum Los Angeles 4) Double Gold San Francisco (largest award in the world for whiskey to earn) 5) Double Gold New York International 6) Double Gold New York Best Fifty 7) Gold Las Vegas 8) Silver Denver Our client has created a supportive community of real fans who love both the founder's music and the bourbon. Our client has taken the brand as far as 26 states. They will soon expand into Canada and exporting to South Africa & Vietnam is on the horizon. The founder and his partner are willing to stay on the team to bring the Bourbon brand to a much higher national level with a well-capitalized strategic buyer or owner-operator who is passionate about the bourbon industry. An NDA is required to secure a comprehensive Confidential Information Memorandum (CIM). Growth & Expansion: In CIM - NDA Required. Financing: If the price and deal structure is right Support & Training: Provided at no charge to enable a smooth transition Reason for Selling: Other Projects
Los Angeles, California
B2B IoT Marketing Platform Available Now
$ 490,000
CF : $ 140,400
Our client operates a lean, high-margin B2B lead-generation platform dedicated to the Internet of Things sector. By leveraging a permission-based community of over 60,000 vetted IoT decision-makers and a LinkedIn Group of 20,000+ approved professionals, they deliver turnkey sponsored webinars, white-paper campaigns, and targeted email blasts—providing technology vendors with consistently qualified leads while maintaining minimal overhead through a fully remote, contractor-driven model. NDA is required for comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Irvine, California
Pharmaceutical Company - Targeting Drug Delivery
$ 20,000,000
Patented Universal Tumor-Targeting Drug Delivery Platform Co. This pharmaceutical company has developed and patented a universal tumor-targeting drug-delivery platform that can improve the safety and efficacy of many existing chemo treatments, with the ability to target numerous different types of cancer. The technology encapsulates existing FDA-approved drugs inside lipid nanoparticles (liposomes or emulsions) coated with patented human-sourced antinuclear antibodies (ANA). The lipid nanoparticle provides long-term storage stability of the drug and controlled release of the drug over time at body-temperature, and is expected to improve the safety and efficacy profile of the drug, including passive accumulation at the tumor while not harming normal tissues. The Company's ANA, sourced from lupus patients, binds to nuclear material present in abundance in areas of necrosis (dead / ruptured cells) present in and around all solid tumors, thus anchoring the drug-filled nanoparticles at the tumor where the nanoparticle is designed to slowly release the drug directly on the tumor for more effect. As the Company's ANA is not tumor-marker specific, but rather targets necrosis present in solid tumors, the technology is designed to "universally" target many different types of cancer including breast cancer, lung, ovarian, colon, prostate, etc., as well as rare childhood cancers. The Company completed a successful proof-of-concept study at Children's Hospital using Ewing's Sarcoma transplanted in immunodeficient mice. Treatment with the Company's forumlation significantly inhibited tumor growth and extended survival times compared to control mice receiving no treatment or treatment with plain liposomal doxorubicin. The Company has been granted Orphan Drug Designation by the FDA on 2 of the lead drug formulations, providing FDA fee waivers, priority review, and 7-years exclusivity upon market approval. The orphan pathway also enables the potential for New Drug Approval after successful completion of Phase 2 studies, with Phase III data collected while in the market, thus significantly lowering the time and cost to market approval. This same drug inside the Company's tumor targeting delivery system will likely have potential to treat other pediatric cancers, and/or cancers in larger adult populations. As the Company's platform and ANA has the potential to improve the safety and efficacy of many existing FDA approved drugs or even compounds in development, the Company anticipates the potential for multiple licensing agreements with multiple pharmaceutical companies seeking to improve their existing portfolio and extend patient life as they advance into clinical stage. And as it may be possible to file for New Drug Approval following successful Phase II studies, the Company anticipates licensing potential at early clinical stage. Multiple exit opportunities exist with high impact & high ROI. The Company is seeking a supportive capital partner to maintain momentum up to $20M. Funding will be used to advance the lead drug through formal Investigational New Drug enabling studies towards New Drug Approval; estimating $3-5 Million now to advance into clinical studies. Preclinical / animal studies estimate ($3 - 5 Million and 12-18 months); follwed by potential combined Phase I-II clinical study in a rare cancer (approximately 2-3 years and $10M) to potential New Drug Approval, plus additional capital to advance additional drugs in the pipeline simultaneously, thus adding tremendous value to the Company's valuation. Valuations of pharma companies often exceed $100 Million valuation at Phase I (approx. 18 months), and New Drug Approval can exceed valuations above $1 Billion. The Company has numerous, improved high-impact cancer drugs advancing with proper support. NDA is required for comprehensive Confidential Information Memorandum crafted by ProNova Partners. Detailed Information Competition: Trying to improve existing therapies and develop novel approaches to hard to treat cancers. Growth & Expansion: Huge market potential. Financing: If the price and deal structure is right. Support & Training: Transition team included. Reason for Selling: Seeking supportive capital partners to take to the next level(s). .
Manhattan, New York
Unrivaled Software Tech for VAR Hardware Resellers
Call/Email
CF : $ 1,100,000
As technology has become and will continue to become a driving factor within economies worldwide, the marketplace for Value Added Resellers (VARs) is growing at an astounding rate with an expected CAGR of 10% Year-over-Year through the year 2028. What makes VARs necessary within the business landscape - most large and medium-sized Companies do not order enough volume for purchasing direct from a manufacturer and can benefit from purchasing from a go-between such as a VAR, thereby creating a strong need for participants within the marketplace who function as a go-between within a B2B environment. For a VAR to maintain a livelihood and grow within this highly competitive marketplace, Resellers must have access to attractively priced goods from manufacturers, resellers, and wholesalers, and the necessary technologies to help streamline business and ensure that pricing opportunities are not overlooked (on the part of the VAR and their customer). The firms which can capture most and/or all sales within the Reseller industry will be the firms who will prevail in the years to come, ideally those who have the capability for: -Displaying a high capacity for tech solutions and customizations -An abundance of data analysis and KPIs -Sales and marketing -Quoting and sourcing -and overall Integrations and customizations Since opening its doors nearly 20 years ago this Company has created a software solution for quoting, procurement, discounting, a vast array of KPIs, and a content library that in sum is yet to be rivaled by other firms in the space. By creating the necessary relations with only the most optimal suppliers for maintaining a reputation of quality while maintaining an outstanding profit margin, it is these factors while developing strategies and sales channels that the Company has been able to boast $3MM-$4MM in gross sales in its pre-covid year. With their most recent integrations (within the last 1-2 years) the Company is NOW able to harness the expected growth within the reseller space and is expecting a massive adoption of this technology among the resellers who are aware of the demand and the impact of tech integration with these capabilities Key Investment Considerations: o Over $10M investment into the platform development, o 5000+ Tech resellers serviced, o $32B of transactions in the last 3 Years, o Presence in the US, CA, IN, SL o Full-fledged India Center with Development, QA, Marketing, and Sales team o Development team in Sri Lanka o 55%+ profitability over the last 3 years o Cloud native SaaS platform o Turnkey system and solid foundation for growth o Robust growth potential and strategies that have been clearly defined and identified by the Seller o Strong customer and referral base years of premium service offering leading reputation for quality products and pricing o 20+ years in the making o Strong process for instilling R&D and maintaining an elevated level of Quality Control o Robust and unique one-of-a-kind content library The Company and brand are very well established and only need a directed effort related to marketing and the Company can far exceed past sales levels. With proper marketing and underbidding on available contracts there are massive growth opportunities available to a new Owner. NDA is required to secure a comprehensive Confidential Information Memorandum (CIM).
Costa Mesa, California
First Responder Accessory Company
Call/Email
CF : $ 65,000
This is in the presentation of a well-established high-performance gear and bag company for First Responders - Fire, Police, and EMS professionals. The strongly established foundation that is being sold due to changes and personal circumstances has strong profit margins with a steady and repeatable process for income including an opportunity for growth; very little marketing spending and strong word of mouth and organic growth. Key Investment Considerations: * There is No other Company that is offering a similar service essentially in a league all of their own * Nearly all income is from repeat business where they have been able to sustain and grow only through word-of-mouth marketing * Owner is a former Fireman who knows, understands, and has built to spec the items for professionals within Police, Fire, and EMTs which can withstand heavy wear and tear * By using subcontractors so that products are built to spec and offer the highest quality to the professionals in these spaces * Once a client is turned on to these products, they are in essence a client for life * The Company uses only top-tier materials and a proprietary process for assembly ensuring a lifetime warranty on all products * High-quality workmanship and products that are built to last * With their established marketplace and strong clientele what is needed at this point in time is a directed marketing effort With proper marketing and pursuant to bidding on available contracts there are massive growth opportunities available to a new owner considering reputation and company processes. NDA is required to secure a comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Facilities: Not available, would need new Company location. Competition: Yes, however processes have been able to in a number of ways keep the Company ahead of the competition. Growth & Expansion: Abundant growth opportunities; little to no marketing up to this point, the flip of a switch, and the company can experience significant growth in the years to come. Financing: Depending on offer and structure may be acceptable. Support & Training: As needed. Reason for Selling: Personal Reasons - Retirement
San Jose, California
P2P Decentralized Free Market Blockchain Platform
$ 250,000
CF : $ 6,750
Our client has an innovative blockchain platform that operates as a digital marketplace where users can create coins and smart contracts to trade assets, goods, and services using a digitally encrypted, peer-to-peer blockchain exchange system. With our client's platform, users can create, transact, and destroy any digital asset or smart contract in their personal E-Vault utilizing the Ethereum blockchain. In short, our client's platform essentially replaces traditional dependency upon third-party market vendors, such as banks, to make transactions or legally binding contracts. Our client's platform provides a unique capacity for users to easily create digital assets of their choosing to trade in a digital marketplace. With the addition of smart contracts, to provide functions such as mint/burn coin, automate interest rates, collateralize smart contracts, and much more. The value of an asset created by each user is set by the market value. The asset itself may be tangible, for example, a gold-backed digital coin or as intangible like time, such as volunteer or billable hours. Our client's software is run by a hybrid platform/blockchain Decentralized Autonomous Organization (DAO). There are 300 main Spartan Nodes that verify all transactions using similar technology to Solana's quick blockchain speeds by predesignating which node will solve which block. This allows more than 100,000 transactions per second making our client's software the fastest blockchain layer 2 solution that could easily compete with Visa/Mastercard along with the P2P transactions being free! Anyone can also download a node from our client that has the full history and syncs through the blockchain instantly but does not verify any transactions like the main 300 Spartan nodes do. Top 10 Features: 1. Decentralized Exchange w/ over 1,700+ coins 2. Lightning & (soon to be) Raiden Network offers FREE instant transactions 3. Create advanced ERC-20 tokens with imbedded DeFi smart contracts 4. Register ANY real world item as NFT on ETH 5. Create vital records such as birth certificates or last will 6. GNEISS network allows free text and soon free audio/video calls 7. History gives the ENTIRE transaction history for an Evault 8. Verify identity using BasisID with top biometrics in the world and (here soon) credit score 9. Coming soon - DeFi copy of AAVE and margin trading using it 10. Coming later - Multisig Wallets, DAOs, Airdrop, Voting, Swap, Betting, BTC & ETH block inscription) Our client's software is 'ready to go;' and is operating with customers and cash flow. NDA is required to secure comprehensive Confidential Information Memorandum (CIM). Detailed Information Facilities: N/A Growth & Expansion: Unlimited world wide. Financing: Sellers will consider, BitCoin preferred Support & Training: As needed specific terms for transition support can be negotiated. The Seller wishes to facilitate a successful and smooth transfer of the Business. Reason for selling: Expansion.
Cleveland, Ohio
Proprietary Organic Plant Based Pizza Dough Co
$ 300,000
CF : $ 15,420
This established LLC is offering its proprietary organic dough mixture for sale. A trademark is in place. The creator/owner is a lifelong baker and began experiencing health-related gut issues, as millions of people do. In response, she embarked on a research journey and sourced products from everywhere possible to make a perfect 100% clean, plant-based, organic pizza dough. She wanted to provide pesticide-free dough that could last longer in the fridge, that could take the heat without burning to a crisp and could be boiled, fried, baked, and grilled. She created a dough that could be used every day, in a variety of ways, that wouldn't make you sick. In other words, eating clean, organic dough like the Europeans! Thus, the Company was born! Currently offered in over 300 grocery stores, in both frozen and dry mixes, in a variety of flavors, at a very competitive price point. NDA is required to secure a comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information: organic yeast, no chemicals Facilities: none Not applicable with this book. Competition: Other health food-based dough mixes that typically are not organic and sell at a higher price point. Growth & Expansion: Unlimited room for expansion and growth in brick-and-mortar stores, as well as online sales and wholesale opportunities. Financing: TBD if structure and terms are acceptable. Royalties are of interest. Support & Training: To ensure a smooth transition and ongoing success the Sellers will work with a buyer as needed for three months, as an on-call consultant, or as negotiated. The seller will introduce the current production/packaging vendor relationship. Reason for Selling: The Seller has developed and runs another business, and is looking to focus her efforts there.
Los Angeles, California
Gene And Cell Therapy Regulatory Consulting
Call/Email
CF : $ 1,144,000
Founded in 2011, the Company is a niche consulting and advisory firm serving in cell therapy, gene and gene-modified cell therapies, other regenerative medicines, tissue engineering, and cell-based drug discovery. The company's core focus is to improve cell & gene therapy innovations by providing consulting services for improving business strategy and achieving major regulatory milestones for companies. The Company has created a one-stop shop for all aspects of cell therapy and gene therapy, including quality checks, regulatory meetings, and submissions with the help of leading experts worldwide. The leadership has a unique combination of experience in the academic, biotech industry, government/FDA, and consulting. They serve biotech, pharma companies, consulting services for healthcare providers, subcontracts for other consulting firms, and contracts with government organizations, which enables them to have 6x+ growth in net income from 2019 2021, i.e., $179,000 to $1,095,000 with the help of 110+ customers served over the past six years. The Company's plan is to consummate a transaction with a supportive growth partner in order to accelerate the company's cell and gene therapy market growth by interacting with industry, academia, government, and other international stakeholders in cell & gene therapies and cell-based drug discovery. NDA is required to secure comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information Facilities: Has headquarters in US contractors operate nationwide / portable / buyer can be located worldwide. Competition: A few competitors in the space are in the field but the Company provides best in class services for its respective niche(s). Growth & Expansion: Continually grow and become more profitable with the help of experts that supports preclinical, clinical, and commercial advisory in the manufacturing, regulatory affairs, Quality/GxP, and M&A arenas. Financing: If the price and deal structure is right. Support & Training: Long term transition, Seller wishes to smooth the transition to maximize success with the Company post-closing and spearhead continued growth. Reason for Selling: Growth.
Recommended Blogs
Business Broker Information
Should Owners Hire Agents To Sell Business Listings?
How To Sell A Business
Selling A Business Online - Common Mistakes To Avoid
Deal And Escrow Issues
Selling A California Small Business? This Checklist Will Determine Your Success
Business Valuation Issues
Interpreting Reported Earnings From Sellers
Buying A Business
Allocation Of The Purchase Price When Selling A California Small Business
Business Purchase Financing
6 Possible Untruths Told To Business Buyers When Buying A Small Business
Buying A Business
How To Create A Business Plan For A Small Business
Buying A Business
Top 5 Industries Of The Future For Business Buyers Of Small Businesses
How To Buy A Business
Retiring Baby Boomers And Their Effect On California Small Business Sales
Deal And Escrow Issues
Qualifying Business Buyers: Top Business Broker Discusses Top Strategies
How To Sell A Business
How to Sell Your Small Business: Tips For Selling Your Small Business
Business Purchase Financing
Pro Tips: Selling Your Note For Top Dollar After Selling Your Business
Deal And Escrow Issues
Avoiding The LOI: Why This Business Broker Favors APAs Over LOIs
Buying A Business
Buying A Small Business: Earnest Money Deposits Should Be Reasonable
How To Sell A Business
8 Questions You Most Likely Will Be Asked When Selling Your Business
Deal And Escrow Issues
Business Owners: Do Not Make It Hard To Buy Your Small Business
Business Broker Information
Before You Select A Business Broker - Do They Co-Broker?
Business Purchase Financing
Getting Financing To Buy A Business Or Franchise - 4 Ideas From A Pro
Buying A Business
6 Reasons You Should Consider Buying a Commercial Cleaning Franchise
How To Sell A Business
How to Sell a Business?